BITTERROOT BIO
Live / Applied — Fourth extension granted (statement of use) (as of 08 May 2025)
What this means for you
Not registered yet, but its 21 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97037427
- Mark type
- Stylized text
- Filed
- 21 Sept 2021
- Published for opposition
- 04 Apr 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of cardiovascular disease, arterial disease, and atherosclerosis, none of the aforementioned featuring or containing bitterroot plant
Owner
- Bitterroot Bio, Inc., Palo Alto, CA, US
- Bitterroot Bio, Inc., Palo Alto, CA, US
Prosecution history
- 29 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2025 — SOU EXTENSION 4 GRANTED
- 08 May 2025 — SOU EXTENSION 4 FILED
- 08 May 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Sept 2024 — SOU EXTENSION 3 GRANTED
- 27 Sept 2024 — SOU EXTENSION 3 FILED
- 27 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 18 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2024 — SOU EXTENSION 2 GRANTED
- 17 May 2024 — SOU EXTENSION 2 FILED
- 17 May 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED